TrialInternational journal of cancer2020

Phase II, 2-stage, 2-arm, PIK3CA mutation stratified trial of MK-2206 in recurrent endometrial cancer.

Andrea P Myers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.